- Home
- AFCG
AFCG
AFC Gamma Inc.
as 06-20-2025 3:30pm EST
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | WEST PALM BEACH |
| Market Cap: | 127.4M | IPO Year: | 2021 |
| Target Price: | $11.00 | AVG Volume (30 days): | 228.5K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.96 | EPS Growth: | 84.02 |
| 52 Week Low/High: | $4.32 - $10.88 | Next Earning Date: | 08-06-2025 |
| Revenue: | $41,036,509 | Revenue Growth: | -5.60% |
| Revenue Growth (this year): | -15.6% | Revenue Growth (next year): | 17.96% |
Stock Insider Trading Activity of AFC Gamma Inc. (AFCG)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Neville Daniel | AFCG | Chief Executive Officer | Mar 28 '25 | Buy | $6.15 | 5,000 | $30,750.00 | 187,261 | |
| Neville Daniel | AFCG | Chief Executive Officer | Mar 26 '25 | Buy | $6.20 | 5,000 | $31,000.00 | 187,261 |
Latest AFC Gamma Inc. News
AFCG Breaking Stock News: Dive into AFCG Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
Advanced Flower Capital Announces Dividend for the Second Quarter 2025
GlobeNewswire
12 days ago
Advanced Flower Capital Expands Revolving Credit Facility with $20 Million Additional Commitment from Existing FDIC-Insured Banking Partner
Yahoo Finance Video
20 days ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
20 days ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
GlobeNewswire
20 days ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
GlobeNewswire
20 days ago
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
PR Newswire
20 days ago
Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
CNW Group
20 days ago
Statement by Minister Guilbeault on Portuguese Heritage Month
Compare AFCG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AFCG AFC Gamma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.